Parkinsons Disease Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Parkinson's Disease Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinson's Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parkinson's Disease Therapeutics Overall Market Size
2.1 Global Parkinson's Disease Therapeutics Market Size: 2023 VS 2030
2.2 Global Parkinson's Disease Therapeutics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Parkinson's Disease Therapeutics Players in Global Market
3.2 Top Global Parkinson's Disease Therapeutics Companies Ranked by Revenue
3.3 Global Parkinson's Disease Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Parkinson's Disease Therapeutics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Parkinson's Disease Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Parkinson's Disease Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Parkinson's Disease Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Parkinson's Disease Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Parkinson's Disease Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Sinemet-CR
4.1.3 Trastal
4.1.4 Madopar
4.1.5 COMT Inhibitor
4.1.6 Other
4.2 By Type - Global Parkinson's Disease Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Parkinson's Disease Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Parkinson's Disease Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Parkinson's Disease Therapeutics Market Size, 2023 & 2030
5.1.2 Under 40 Years Old
5.1.3 40-65 Years Old
5.1.4 Above 65 Years Old
5.2 By Application - Global Parkinson's Disease Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Parkinson's Disease Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Parkinson's Disease Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Parkinson's Disease Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Parkinson's Disease Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Parkinson's Disease Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Parkinson's Disease Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Parkinson's Disease Therapeutics Revenue, 2019-2030
6.3.2 US Parkinson's Disease Therapeutics Market Size, 2019-2030
6.3.3 Canada Parkinson's Disease Therapeutics Market Size, 2019-2030
6.3.4 Mexico Parkinson's Disease Therapeutics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Parkinson's Disease Therapeutics Revenue, 2019-2030
6.4.2 Germany Parkinson's Disease Therapeutics Market Size, 2019-2030
6.4.3 France Parkinson's Disease Therapeutics Market Size, 2019-2030
6.4.4 U.K. Parkinson's Disease Therapeutics Market Size, 2019-2030
6.4.5 Italy Parkinson's Disease Therapeutics Market Size, 2019-2030
6.4.6 Russia Parkinson's Disease Therapeutics Market Size, 2019-2030
6.4.7 Nordic Countries Parkinson's Disease Therapeutics Market Size, 2019-2030
6.4.8 Benelux Parkinson's Disease Therapeutics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Parkinson's Disease Therapeutics Revenue, 2019-2030
6.5.2 China Parkinson's Disease Therapeutics Market Size, 2019-2030
6.5.3 Japan Parkinson's Disease Therapeutics Market Size, 2019-2030
6.5.4 South Korea Parkinson's Disease Therapeutics Market Size, 2019-2030
6.5.5 Southeast Asia Parkinson's Disease Therapeutics Market Size, 2019-2030
6.5.6 India Parkinson's Disease Therapeutics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Parkinson's Disease Therapeutics Revenue, 2019-2030
6.6.2 Brazil Parkinson's Disease Therapeutics Market Size, 2019-2030
6.6.3 Argentina Parkinson's Disease Therapeutics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Parkinson's Disease Therapeutics Revenue, 2019-2030
6.7.2 Turkey Parkinson's Disease Therapeutics Market Size, 2019-2030
6.7.3 Israel Parkinson's Disease Therapeutics Market Size, 2019-2030
6.7.4 Saudi Arabia Parkinson's Disease Therapeutics Market Size, 2019-2030
6.7.5 UAE Parkinson's Disease Therapeutics Market Size, 2019-2030
7 Parkinson's Disease Therapeutics Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Parkinson's Disease Therapeutics Major Product Offerings
7.1.4 Merck Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.1.5 Merck Key News & Latest Developments
7.2 Akorn
7.2.1 Akorn Company Summary
7.2.2 Akorn Business Overview
7.2.3 Akorn Parkinson's Disease Therapeutics Major Product Offerings
7.2.4 Akorn Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.2.5 Akorn Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Parkinson's Disease Therapeutics Major Product Offerings
7.3.4 GSK Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.3.5 GSK Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Parkinson's Disease Therapeutics Major Product Offerings
7.4.4 Novartis Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.4.5 Novartis Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Major Product Offerings
7.5.4 Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Company Summary
7.6.2 Teva Pharmaceutical Business Overview
7.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Major Product Offerings
7.6.4 Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.6.5 Teva Pharmaceutical Key News & Latest Developments
7.7 Abbvie
7.7.1 Abbvie Company Summary
7.7.2 Abbvie Business Overview
7.7.3 Abbvie Parkinson's Disease Therapeutics Major Product Offerings
7.7.4 Abbvie Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.7.5 Abbvie Key News & Latest Developments
7.8 Kyowa Hakko Kirin Pharma
7.8.1 Kyowa Hakko Kirin Pharma Company Summary
7.8.2 Kyowa Hakko Kirin Pharma Business Overview
7.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Major Product Offerings
7.8.4 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.8.5 Kyowa Hakko Kirin Pharma Key News & Latest Developments
7.9 Astellas Pharma
7.9.1 Astellas Pharma Company Summary
7.9.2 Astellas Pharma Business Overview
7.9.3 Astellas Pharma Parkinson's Disease Therapeutics Major Product Offerings
7.9.4 Astellas Pharma Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.9.5 Astellas Pharma Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Parkinson's Disease Therapeutics Major Product Offerings
7.10.4 Roche Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.10.5 Roche Key News & Latest Developments
7.11 H.Lundbeck
7.11.1 H.Lundbeck Company Summary
7.11.2 H.Lundbeck Business Overview
7.11.3 H.Lundbeck Parkinson's Disease Therapeutics Major Product Offerings
7.11.4 H.Lundbeck Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.11.5 H.Lundbeck Key News & Latest Developments
7.12 Bausch Health
7.12.1 Bausch Health Company Summary
7.12.2 Bausch Health Business Overview
7.12.3 Bausch Health Parkinson's Disease Therapeutics Major Product Offerings
7.12.4 Bausch Health Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.12.5 Bausch Health Key News & Latest Developments
7.13 Apokyn
7.13.1 Apokyn Company Summary
7.13.2 Apokyn Business Overview
7.13.3 Apokyn Parkinson's Disease Therapeutics Major Product Offerings
7.13.4 Apokyn Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.13.5 Apokyn Key News & Latest Developments
7.14 Orion
7.14.1 Orion Company Summary
7.14.2 Orion Business Overview
7.14.3 Orion Parkinson's Disease Therapeutics Major Product Offerings
7.14.4 Orion Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.14.5 Orion Key News & Latest Developments
7.15 Stada Arzneimittel
7.15.1 Stada Arzneimittel Company Summary
7.15.2 Stada Arzneimittel Business Overview
7.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Major Product Offerings
7.15.4 Stada Arzneimittel Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.15.5 Stada Arzneimittel Key News & Latest Developments
7.16 US WorldMeds
7.16.1 US WorldMeds Company Summary
7.16.2 US WorldMeds Business Overview
7.16.3 US WorldMeds Parkinson's Disease Therapeutics Major Product Offerings
7.16.4 US WorldMeds Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.16.5 US WorldMeds Key News & Latest Developments
7.17 Desitin Arzneimittel
7.17.1 Desitin Arzneimittel Company Summary
7.17.2 Desitin Arzneimittel Business Overview
7.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Major Product Offerings
7.17.4 Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.17.5 Desitin Arzneimittel Key News & Latest Developments
7.18 Endo Pharmaceuticals
7.18.1 Endo Pharmaceuticals Company Summary
7.18.2 Endo Pharmaceuticals Business Overview
7.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Major Product Offerings
7.18.4 Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue in Global Market (2019-2024)
7.18.5 Endo Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Parkinson's Disease Therapeutics Market Opportunities & Trends in Global Market
Table 2. Parkinson's Disease Therapeutics Market Drivers in Global Market
Table 3. Parkinson's Disease Therapeutics Market Restraints in Global Market
Table 4. Key Players of Parkinson's Disease Therapeutics in Global Market
Table 5. Top Parkinson's Disease Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Parkinson's Disease Therapeutics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Parkinson's Disease Therapeutics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Parkinson's Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Parkinson's Disease Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinson's Disease Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Parkinson's Disease Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Parkinson's Disease Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Parkinson's Disease Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Parkinson's Disease Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Parkinson's Disease Therapeutics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Parkinson's Disease Therapeutics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2025-2030
Table 30. Merck Company Summary
Table 31. Merck Parkinson's Disease Therapeutics Product Offerings
Table 32. Merck Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 33. Merck Key News & Latest Developments
Table 34. Akorn Company Summary
Table 35. Akorn Parkinson's Disease Therapeutics Product Offerings
Table 36. Akorn Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 37. Akorn Key News & Latest Developments
Table 38. GSK Company Summary
Table 39. GSK Parkinson's Disease Therapeutics Product Offerings
Table 40. GSK Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 41. GSK Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Parkinson's Disease Therapeutics Product Offerings
Table 44. Novartis Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 45. Novartis Key News & Latest Developments
Table 46. Boehringer Ingelheim Company Summary
Table 47. Boehringer Ingelheim Parkinson's Disease Therapeutics Product Offerings
Table 48. Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 49. Boehringer Ingelheim Key News & Latest Developments
Table 50. Teva Pharmaceutical Company Summary
Table 51. Teva Pharmaceutical Parkinson's Disease Therapeutics Product Offerings
Table 52. Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 53. Teva Pharmaceutical Key News & Latest Developments
Table 54. Abbvie Company Summary
Table 55. Abbvie Parkinson's Disease Therapeutics Product Offerings
Table 56. Abbvie Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 57. Abbvie Key News & Latest Developments
Table 58. Kyowa Hakko Kirin Pharma Company Summary
Table 59. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Offerings
Table 60. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 61. Kyowa Hakko Kirin Pharma Key News & Latest Developments
Table 62. Astellas Pharma Company Summary
Table 63. Astellas Pharma Parkinson's Disease Therapeutics Product Offerings
Table 64. Astellas Pharma Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 65. Astellas Pharma Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Parkinson's Disease Therapeutics Product Offerings
Table 68. Roche Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 69. Roche Key News & Latest Developments
Table 70. H.Lundbeck Company Summary
Table 71. H.Lundbeck Parkinson's Disease Therapeutics Product Offerings
Table 72. H.Lundbeck Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 73. H.Lundbeck Key News & Latest Developments
Table 74. Bausch Health Company Summary
Table 75. Bausch Health Parkinson's Disease Therapeutics Product Offerings
Table 76. Bausch Health Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 77. Bausch Health Key News & Latest Developments
Table 78. Apokyn Company Summary
Table 79. Apokyn Parkinson's Disease Therapeutics Product Offerings
Table 80. Apokyn Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 81. Apokyn Key News & Latest Developments
Table 82. Orion Company Summary
Table 83. Orion Parkinson's Disease Therapeutics Product Offerings
Table 84. Orion Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 85. Orion Key News & Latest Developments
Table 86. Stada Arzneimittel Company Summary
Table 87. Stada Arzneimittel Parkinson's Disease Therapeutics Product Offerings
Table 88. Stada Arzneimittel Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 89. Stada Arzneimittel Key News & Latest Developments
Table 90. US WorldMeds Company Summary
Table 91. US WorldMeds Parkinson's Disease Therapeutics Product Offerings
Table 92. US WorldMeds Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 93. US WorldMeds Key News & Latest Developments
Table 94. Desitin Arzneimittel Company Summary
Table 95. Desitin Arzneimittel Parkinson's Disease Therapeutics Product Offerings
Table 96. Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 97. Desitin Arzneimittel Key News & Latest Developments
Table 98. Endo Pharmaceuticals Company Summary
Table 99. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Offerings
Table 100. Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 101. Endo Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Parkinson's Disease Therapeutics Segment by Type in 2023
Figure 2. Parkinson's Disease Therapeutics Segment by Application in 2023
Figure 3. Global Parkinson's Disease Therapeutics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Parkinson's Disease Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Parkinson's Disease Therapeutics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2023
Figure 8. By Type - Global Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
Figure 9. By Application - Global Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
Figure 10. By Type - Global Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
Figure 12. By Application - Global Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
Figure 14. By Region - Global Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
Figure 15. By Country - North America Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
Figure 16. US Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
Figure 20. Germany Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 21. France Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
Figure 28. China Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 32. India Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
Figure 34. Brazil Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Parkinson's Disease Therapeutics Revenue Market Share, 2019-2030
Figure 37. Turkey Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 41. Merck Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Akorn Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. GSK Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Novartis Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Abbvie Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Astellas Pharma Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Roche Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. H.Lundbeck Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Bausch Health Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Apokyn Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Orion Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Stada Arzneimittel Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. US WorldMeds Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
